Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. claims carbapenems active against methicillin-resistant staphylococci

Jan. 19, 1998

Peptide HIV protease inhibitors claimed by Merck & Co.

Jan. 19, 1998

Thienopyridine derivatives for arthritis, osteoporosis from Takeda

Jan. 19, 1998

New agents for cancer discovered at Zeneca

Jan. 19, 1998

Novel CNS agents disclosed by HMR

Jan. 19, 1998

More dopaminergic agents in the pipeline at Neurogen

Jan. 19, 1998

New therapeutic tetrahydrofuran derivatives from Janssen

Jan. 19, 1998

U. of Mass. scientists design anti-EBV antisense oligonucleotides

Jan. 16, 1998

Lilly claims another series of heterocyclic muscarinic receptor modulators

Jan. 16, 1998

Takeda discloses compounds for cachexia

Jan. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...